Genetic investigations of kidney disease: Core curriculum 2013

American Journal of Kidney Diseases

Volumn 61, Issue 5, 2013, Pages 832-844

  Li, Yong ^a   Köttgen, Anna ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC KIDNEY DISEASE; CURRICULUM; GENE FREQUENCY; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; INHERITANCE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LINKAGE ANALYSIS; NEPHRONOPHTHISIS; RENAL SYSTEM PARAMETERS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CURRICULUM; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY DISEASES; UNITED STATES;

EID: 84876295983     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.11.052     Document Type: Article

References (55)

1. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073- 2081.
2. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17): 2038-2047.
3. Lifton RP, Somlo S, Giebisch GH, Seldin DW. Genetic Diseases of the Kidney. San Diego, CA: Elsevier; 2009.
4. Thomas DC. Overview of genetic epidemiology. In: Thomas DC. Statistical Methods in Genetic Epidemiology. New York, NY: Oxford University Press; 2004:3-22.
5. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117.
6. Bochud M, Elston RC, Maillard M, et al. Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean). Kidney Int. 2005;67(1):61-69.
7. Fava C, Montagnana M, Burri P, et al. Determinants of kidney function in Swedish families: role of heritable factors. J Hypertens. 2008;26(9):1773-1779.
8. Fox CS, Yang Q, Cupples LA, et al. Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. J Am Soc Nephrol. 2004;15(9):2457-2461.
9. Langefeld CD, Beck SR, Bowden DW, Rich SS, Wagenknecht LE, Freedman BI. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis. 2004;43(5):796-800.
10. Lei HH, Perneger TV, Klag MJ, Whelton PK, Coresh J. Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol. 1998;9(7):1270-1276.
11. Almasy L, Blangero J. Contemporary model-free methods for linkage analysis. In: Rao DC, Gu CC, eds. Genetic Dissection of Complex Traits. 2nd ed. London, UK: Academic Press; 2008:175-193.
12. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366(9483):371-377.
13. European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell. 1994;77(6):881-894.
14. Hughes J, Ward CJ, Peral B, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet. 1995;10(2):151-160.
15. Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996;272(5266):1339- 1342.
16. Rice JP, Saccone NL, Corbett J. Model-based methods for linkage analysis, and contemporary model-free methods for linkage analysis. In: Rao DC, Gu CC, eds. Genetic Dissection of Complex Traits. 2nd ed. London, UK: Academic Press; 2008:155-174.
17. Al-Romaih KI, Genovese G, Al-Mojalli H, et al. Genetic diagnosis in consanguineous families with kidney disease by homozygosity mapping coupled with whole-exome sequencing. Am J Kidney Dis. 2011;58(2):186-195.
18. Bamshad MJ, Ng SB, Bigham AW, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12(11):745-755.
19. ENCODE Project Consortium, Dunham I, Kundaje A, Aldred SF, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57-74.
20. Hildebrandt F. Genetic kidney diseases. Lancet. 2010; 375(9722):1287-1295.
21. Lander ES, Botstein D. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science. 1987;236(4808):1567-1570.
22. Metzker ML. Sequencing technologiesthe next generation. Nat Rev Genet. 2010;11(1):31-46.
23. Otto EA, Hurd TW, Airik R, et al. Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinalrenal ciliopathy. Nat Genet. 2010;42(10):840-850.
24. Ovunc B, Otto EA, Vega-Warner V, et al. Exome sequencing reveals cubilin mutation as a single-gene cause of proteinuria. J Am Soc Nephrol. 2011;22(10):1815-1820.
25. Böger CA, Chen MH, Tin A, et al. CUBN is a gene locus for albuminuria. J Am Soc Nephrol. 2011;22(3):555-570.
26. Chambers JC, Zhang W, Lord GM, et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet. 2010;42(5):373-375.
27. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329(5993):841-845.
28. Gharavi AG, Kiryluk K, Choi M, et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet. 2011;43(4):321-327.
29. Hsu CC, Kao WH, Coresh J, et al. Apolipoprotein E and progression of chronic kidney disease. JAMA. 2005;293(23): 2892-2899.
30. Kao WH, Klag MJ, Meoni LA, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 2008;40(10):1185-1192.
31. Kopp JB, Smith MW, Nelson GW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008;40(10):1175-1184.
32. Köttgen A. Genome-wide association studies in nephrology research. Am J Kidney Dis. 2010;56(4):743-758.
33. Köttgen A Pattaro C, Böger CA, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42(5) 376-384
34. Köttgen A, Pattaro C, Böger CA, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42(5):376-384.
35. McKnight AJ, Currie D, Maxwell AP. Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders. J Pathol. 2010;220(2):198-216.
36. Okada Y, Sim X, Go MJ, et al. Meta-analysis identifies multiple loci associated with kidney function-related traits in East Asian populations. Nat Genet. 2012;44(8):904-909.
37. OSeaghdha CM, Fox CS. Genome-wide association studies of chronic kidney disease: what have we learned? Nat Rev Nephrol. 2011;8(2):89-99.
38. Stanescu HC, Arcos-Burgos M, Medlar A, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med. 2011;364(7):616-626.
39. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet. 2010;11(7):499-511.
40. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet. 2006;7(10):781-791.
41. Devlin B, Roeder K. Genomic control for association studies. Biometrics. 1999;55(4):997-1004.
42. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904-909.
43. Little J, Higgins JP, Ioannidis JP, et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009;6(2): e22.
44. NCI-NHGRI Working Group on Replication in Association Studies. Replicating genotype-phenotype associations. Nature. 2007;447(7145):655-660.
45. Gallagher AR, Germino GG, Somlo S. Molecular advances in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis. 2010;17(2):118-130.
46. Köttgen A, Hwang SJ, Larson MG, et al. Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol. 2010;21(2):337-344.
47. Freedman BI, Hicks PJ, Bostrom MA, et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int. 2009;75(7):736-745.
48. Pattaro C, Köttgen A, Teumer A, et al. Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet. 2012;8(3):e1002584.
49. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329(5993):841-845.
50. Kiryluk K, Li Y, Sanna-Cherchi S, et al. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012;8(6):e1002765.
51. Huang E, Samaniego-Picota M, McCune T, et al. DNAtesting for live kidney donors at risk for autosomal dominant polycystic kidney disease. Transplantation. 2009;87(1):133-137.
52. OSeaghdha CM, Yang Q, Wu H, Hwang SJ, Fox CS. Performance of a genetic risk score for CKD stage 3 in the general population. Am J Kidney Dis. 2012;59(1):19-24.
53. Burmester JK, Berg RL, Yale SH, et al. A randomized controlled trial of genotype-based Coumadin initiation. Genet Med. 2011;13(6):509-518.
54. Suhre K, Shin SY, Petersen AK, et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011;477(7362):54-60.
55. Zaitlen N, Kraft P. Heritability in the genome-wide association era. Hum Genet. 2012;131(10):1655-1664.